Across TCGA pan-cancer cohorts, SPINK8 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SPINK8 data layer compared with 15 for mass-spec protein.
The strongest signal is observed in sarcoma (SARC), where higher SPINK8 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SPINK8 expression acts as an unfavorable survival marker.
SARC and UCEC are the cancer types where SPINK8 Mutation most reproducibly stratifies survival.